0001179110-17-002192.txt : 20170210 0001179110-17-002192.hdr.sgml : 20170210 20170210192554 ACCESSION NUMBER: 0001179110-17-002192 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170208 FILED AS OF DATE: 20170210 DATE AS OF CHANGE: 20170210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICELL, Inc CENTRAL INDEX KEY: 0000926326 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPUTERS [3571] IRS NUMBER: 943166458 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 590 E. MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6502516100 MAIL ADDRESS: STREET 1: 590 E. MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FORMER COMPANY: FORMER CONFORMED NAME: OMNICELL INC /CA/ DATE OF NAME CHANGE: 20010625 FORMER COMPANY: FORMER CONFORMED NAME: OMNICELL COM /CA/ DATE OF NAME CHANGE: 20000419 FORMER COMPANY: FORMER CONFORMED NAME: OMNICELL TECHNOLOGIES INC DATE OF NAME CHANGE: 19960807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIPPS RANDALL A CENTRAL INDEX KEY: 0001227556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-33043 FILM NUMBER: 17595301 MAIL ADDRESS: STREET 1: 1101 EAST MEADOW DR CITY: PALO ALTO STATE: CA ZIP: 94303 4 1 edgar.xml FORM 4 - X0306 4 2017-02-08 0 0000926326 OMNICELL, Inc OMCL 0001227556 LIPPS RANDALL A C/O OMNICELL, INC. 590 E.MIDDLEFIELD MOUNTAIN VIEW CA 94043 1 1 0 0 Chairman, President, and CEO Common Stock 143034 D Common Stock 393228 I In Trust with Wife Common Stock 15549 I In Trust for Children Common Stock 2017-02-08 4 A 0 16350 0 A 192355 D Common Stock 2017-02-08 4 A 0 54500 0 A 244705 D Stock Option (Right to Buy) 36.70 2017-02-08 4 A 0 134160 0 A 2018-02-08 2027-02-08 Common Stock 134160 134160 D Shares held in trust with Mr. Lipps' wife. Shares held in trust for the benefit of Mr. Lipps' children. Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years. Shares shall vest ratably over 48 month period, with a year cliff. The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2018 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2018 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance. /s/ Randall A. Lipps 2017-02-10